speb/financial-data huggingface dataset:
CY5.AX income_statement (annual, 2022-12-31) — Depreciation Income Statement: 67084.00
CY5.AX income_statement (annual, 2022-12-31) — Diluted Average Shares: 618913430.00
CY5.AX income_statement (annual, 2022-12-31) — Diluted EPS: 0.00
CY5.AX income_statement (annual, 2022-12-31) — EBIT: -2607407.00
CY5.AX income_statement (annual, 2022-12-31) — EBITDA: -2540323.00
CY5.AX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -306260.00
CY5.AX cash_flow (annual, 2022-12-31) — End Cash Position: 13530678.00
CY5.AX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 18200871.00
CY5.AX balance_sheet (annual, 2022-12-31) — Fixed Assets Revaluation Reserve: -56934.00
CY5.AX cash_flow (annual, 2022-12-31) — Free Cash Flow: -6738499.00
CY5.AX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 7051288.00
CY5.AX income_statement (annual, 2022-12-31) — General And Administrative Expense: 1517893.00
CY5.AX balance_sheet (annual, 2022-12-31) — Gross PPE: 5857114.00
CY5.AX income_statement (annual, 2022-12-31) — Gross Profit: 92498.00
CY5.AX income_statement (annual, 2022-12-31) — Interest Income: 5123.00
CY5.AX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 5123.00
CY5.AX cash_flow (annual, 2022-12-31) — Interest Paid Direct: -4510.00
CY5.AX cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 4510.00
CY5.AX cash_flow (annual, 2022-12-31) — Interest Received Direct: 5276.00
CY5.AX balance_sheet (annual, 2022-12-31) — Invested Capital: 17402441.00
CY5.AX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -5066996.00
CY5.AX balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 397895.00
CY5.AX balance_sheet (annual, 2022-12-31) — Investments And Advances: 397895.00
CY5.AX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 18991203.00
CY5.AX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 318257.00
CY5.AX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 18229373.00
CY5.AX income_statement (annual, 2022-12-31) — Net Income: -2320455.00
CY5.AX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -2320455.00
CY5.AX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -2320455.00
CY5.AX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -2320455.00
CY5.AX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -2320455.00
CY5.AX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -2320455.00
CY5.AX income_statement (annual, 2022-12-31) — Net Interest Income: 644.00
CY5.AX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -454830.00
CY5.AX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 644.00
CY5.AX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -57004.00
CY5.AX balance_sheet (annual, 2022-12-31) — Net PPE: 5693824.00
CY5.AX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1319854.00
CY5.AX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 17402441.00
CY5.AX balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 440773.00
CY5.AX balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 440773.00
CY5.AX income_statement (annual, 2022-12-31) — Normalized EBITDA: -2540323.00
CY5.AX income_statement (annual, 2022-12-31) — Normalized Income: -2320455.00
CY5.AX income_statement (annual, 2022-12-31) — Operating Income: -2607407.00
CY5.AX income_statement (annual, 2022-12-31) — Operating Revenue: 92498.00
CY5.AX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 183874212.00
CY5.AX cash_flow (annual, 2022-12-31) — Other Cash Paymentsfrom Operating Activities: -49844.00
CY5.AX cash_flow (annual, 2022-12-31) — Other Cash Receiptsfrom Operating Activities: 64919.00
CY5.AX balance_sheet (annual, 2022-12-31) — Other Current Assets: 20000.00
CY5.AX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 7108222.00
CY5.AX income_statement (annual, 2022-12-31) — Other Gand A: 443820.00
CY5.AX income_statement (annual, 2022-12-31) — Other Income Expense: 286308.00
CY5.AX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 286308.00
CY5.AX income_statement (annual, 2022-12-31) — Other Operating Expenses: 1114928.00
CY5.AX balance_sheet (annual, 2022-12-31) — Other Payable: 2252243.00
CY5.AX balance_sheet (annual, 2022-12-31) — Other Properties: 5538857.00
CY5.AX balance_sheet (annual, 2022-12-31) — Payables: 3530497.00
CY5.AX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 3530497.00
CY5.AX cash_flow (annual, 2022-12-31) — Paymentsto Suppliersfor Goodsand Services: -2124114.00
CY5.AX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1592006.00
CY5.AX income_statement (annual, 2022-12-31) — Pretax Income: -2320455.00
CY5.AX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -454830.00
CY5.AX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1337914.00
CY5.AX balance_sheet (annual, 2022-12-31) — Receivables: 167267.00
CY5.AX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 67084.00
CY5.AX income_statement (annual, 2022-12-31) — Rent And Landing Fees: 38823.00
CY5.AX cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -761830.00
CY5.AX balance_sheet (annual, 2022-12-31) — Retained Earnings: -14909491.00
CY5.AX income_statement (annual, 2022-12-31) — Salaries And Wages: 1035250.00
CY5.AX cash_flow (annual, 2022-12-31) — Sale Of PPE: 18060.00
CY5.AX income_statement (annual, 2022-12-31) — Selling General And Administration: 1517893.00
CY5.AX balance_sheet (annual, 2022-12-31) — Share Issued: 183874212.00
CY5.AX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 17402441.00
CY5.AX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 17402441.00
CY5.AX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CY5.AX income_statement (annual, 2022-12-31) — Tax Provision: 0.00
CY5.AX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CY5.AX balance_sheet (annual, 2022-12-31) — Total Assets: 21401670.00
CY5.AX balance_sheet (annual, 2022-12-31) — Total Capitalization: 17402441.00
CY5.AX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 17402441.00
CY5.AX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3999229.00
CY5.AX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 6091719.00
CY5.AX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 440773.00
CY5.AX income_statement (annual, 2022-12-31) — Total Other Finance Cost: 4479.00
CY5.AX balance_sheet (annual, 2022-12-31) — Trading Securities: 397895.00
CY5.AX balance_sheet (annual, 2022-12-31) — Working Capital: 11751495.00
CY5.AX income_statement (annual, 2023-12-31) — +Operating Expense: 14232953.00
CY5.AX income_statement (annual, 2023-12-31) — +Total Revenue: 8700.00
CY5.AX balance_sheet (annual, 2023-12-31) — Accounts Payable: 1931448.00
CY5.AX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 546130.00
CY5.AX income_statement (annual, 2023-12-31) — Basic Average Shares: 231027237.00
CY5.AX income_statement (annual, 2023-12-31) — Basic EPS: -0.06
CY5.AX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 13530678.00
CY5.AX cash_flow (annual, 2023-12-31) — Capital Expenditure: -12875651.00
CY5.AX cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -10998818.00
CY5.AX balance_sheet (annual, 2023-12-31) — Capital Stock: 47607870.00
CY5.AX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 9316782.00
CY5.AX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 9316782.00
CY5.AX balance_sheet (annual, 2023-12-31) — Cash Equivalents: 7432929.00
CY5.AX balance_sheet (annual, 2023-12-31) — Cash Financial: 1883853.00
CY5.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 12504080.00
CY5.AX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -13004601.00
CY5.AX cash_flow (annual, 2023-12-31) — Cash Flowsfromusedin Operating Activities Direct: -3554201.00
CY5.AX cash_flow (annual, 2023-12-31) — Changes In Cash: -4054722.00
CY5.AX cash_flow (annual, 2023-12-31) — Classesof Cash Payments: -3251788.00
CY5.AX cash_flow (annual, 2023-12-31) — Classesof Cash Receiptsfrom Operating Activities: 33000.00
CY5.AX balance_sheet (annual, 2023-12-31) — Common Stock: 47607870.00
CY5.AX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 26977396.00
CY5.AX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 13214700.00
CY5.AX cash_flow (annual, 2023-12-31) — Common Stock Payments: -710620.00
CY5.AX balance_sheet (annual, 2023-12-31) — Current Assets: 10973423.00
CY5.AX balance_sheet (annual, 2023-12-31) — Current Liabilities: 5648480.00
CY5.AX balance_sheet (annual, 2023-12-31) — Current Provisions: 120238.00
CY5.AX income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 51482.00
CY5.AX income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 51482.00
CY5.AX income_statement (annual, 2023-12-31) — Depreciation Income Statement: 51482.00
CY5.AX income_statement (annual, 2023-12-31) — Diluted Average Shares: 231027237.00
CY5.AX income_statement (annual, 2023-12-31) — Diluted EPS: -0.06
CY5.AX income_statement (annual, 2023-12-31) — EBIT: -14224253.00
CY5.AX income_statement (annual, 2023-12-31) — EBITDA: -14172771.00
CY5.AX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -159174.00
CY5.AX cash_flow (annual, 2023-12-31) — End Cash Position: 9316782.00
CY5.AX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 12504080.00
CY5.AX balance_sheet (annual, 2023-12-31) — Fixed Assets Revaluation Reserve: -253132.00
CY5.AX balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: -113473.00
CY5.AX cash_flow (annual, 2023-12-31) — Free Cash Flow: -16429852.00
CY5.AX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 7779313.00
CY5.AX income_statement (annual, 2023-12-31) — General And Administrative Expense: 11549658.00
CY5.AX balance_sheet (annual, 2023-12-31) — Gross PPE: 24059226.00
CY5.AX income_statement (annual, 2023-12-31) — Gross Profit: 8700.00
CY5.AX cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 392507.00
CY5.AX income_statement (annual, 2023-12-31) — Interest Income: 118519.00
CY5.AX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 118519.00
CY5.AX cash_flow (annual, 2023-12-31) — Interest Received Direct: 57094.00
CY5.AX balance_sheet (annual, 2023-12-31) — Invested Capital: 26977396.00
CY5.AX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -13004601.00
CY5.AX balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 201698.00
CY5.AX balance_sheet (annual, 2023-12-31) — Investments And Advances: 201698.00
CY5.AX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 13214700.00
CY5.AX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 132847.00
CY5.AX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 12504080.00
CY5.AX income_statement (annual, 2023-12-31) — Net Income: -13500296.00
CY5.AX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -13500296.00
CY5.AX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -13500296.00
CY5.AX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -13500296.00
CY5.AX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -13500296.00
CY5.AX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -13500296.00
CY5.AX income_statement (annual, 2023-12-31) — Net Interest Income: 118519.00
CY5.AX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -128950.00
CY5.AX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 118519.00
CY5.AX balance_sheet (annual, 2023-12-31) — Net PPE: 24059226.00
CY5.AX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1876833.00
CY5.AX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 26977396.00
CY5.AX balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2459306.00
CY5.AX balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 2459306.00
CY5.AX income_statement (annual, 2023-12-31) — Normalized EBITDA: -14172771.00
CY5.AX income_statement (annual, 2023-12-31) — Normalized Income: -13500296.00
CY5.AX income_statement (annual, 2023-12-31) — Operating Income: -14224253.00
CY5.AX income_statement (annual, 2023-12-31) — Operating Revenue: 8700.00
CY5.AX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 291559139.00
CY5.AX cash_flow (annual, 2023-12-31) — Other Cash Paymentsfrom Operating Activities: -63155.00
CY5.AX cash_flow (annual, 2023-12-31) — Other Cash Receiptsfrom Operating Activities: 33000.00
CY5.AX balance_sheet (annual, 2023-12-31) — Other Current Assets: 149165.00
CY5.AX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 8145918.00
CY5.AX income_statement (annual, 2023-12-31) — Other Income Expense: 2623971.00
CY5.AX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2623971.00
CY5.AX income_statement (annual, 2023-12-31) — Other Operating Expenses: 2631813.00
CY5.AX balance_sheet (annual, 2023-12-31) — Other Payable: 3596794.00
CY5.AX balance_sheet (annual, 2023-12-31) — Other Properties: 23926379.00
CY5.AX balance_sheet (annual, 2023-12-31) — Other Receivables: 149165.00
CY5.AX balance_sheet (annual, 2023-12-31) — Payables: 5528242.00
CY5.AX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 5528242.00
CY5.AX cash_flow (annual, 2023-12-31) — Paymentsto Suppliersfor Goodsand Services: -3188633.00
CY5.AX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 812181.00
CY5.AX income_statement (annual, 2023-12-31) — Pretax Income: -11481763.00
CY5.AX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -128950.00
CY5.AX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1876833.00
CY5.AX balance_sheet (annual, 2023-12-31) — Receivables: 695295.00
CY5.AX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 51482.00
CY5.AX income_statement (annual, 2023-12-31) — Rent And Landing Fees: 155479.00
CY5.AX cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -710620.00
CY5.AX balance_sheet (annual, 2023-12-31) — Retained Earnings: -28409787.00
CY5.AX income_statement (annual, 2023-12-31) — Salaries And Wages: 11394179.00
CY5.AX income_statement (annual, 2023-12-31) — Selling General And Administration: 11549658.00
CY5.AX balance_sheet (annual, 2023-12-31) — Share Issued: 291559139.00
CY5.AX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 26977396.00
CY5.AX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 26977396.00
CY5.AX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CY5.AX income_statement (annual, 2023-12-31) — Tax Provision: 2018533.00
CY5.AX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.30
CY5.AX cash_flow (annual, 2023-12-31) — Taxes Refund Paid Direct: -392507.00
CY5.AX balance_sheet (annual, 2023-12-31) — Total Assets: 35234347.00
CY5.AX balance_sheet (annual, 2023-12-31) — Total Capitalization: 26977396.00
CY5.AX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 26977396.00
CY5.AX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 8107786.00
CY5.AX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 24260924.00
CY5.AX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2459306.00
CY5.AX balance_sheet (annual, 2023-12-31) — Trading Securities: 201698.00
CY5.AX balance_sheet (annual, 2023-12-31) — Working Capital: 5324943.00
CY5.AX income_statement (annual, 2024-12-31) — +Operating Expense: 5197321.00
CY5.AX balance_sheet (annual, 2024-12-31) — Accounts Payable: 2287503.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 2287503.00
CY5.AX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 903513.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 903513.00
CY5.AX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -256877.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -256877.00
CY5.AX income_statement (annual, 2024-12-31) — Basic Average Shares: 349580579.00
CY5.AX income_statement (annual, 2024-12-31) — Basic EPS: -0.01
CY5.AX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 9316782.00
CY5.AX cash_flow (annual, 2024-12-31) — Capital Expenditure: -8378182.00
CY5.AX cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -8097891.00
CY5.AX balance_sheet (annual, 2024-12-31) — Capital Stock: 92739029.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Capital Stock: 92739029.00
CY5.AX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 14869835.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 14869835.00
CY5.AX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 14869835.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 14869835.00
CY5.AX balance_sheet (annual, 2024-12-31) — Cash Financial: 14869835.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Cash Financial: 14869835.00
CY5.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 13322224.00
CY5.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -5874660.00
CY5.AX cash_flow (annual, 2024-12-31) — Cash Flowsfromusedin Operating Activities Direct: -1923096.00
CY5.AX cash_flow (annual, 2024-12-31) — Changes In Cash: 5524468.00
CY5.AX cash_flow (annual, 2024-12-31) — Classesof Cash Payments: -2194788.00
CY5.AX cash_flow (annual, 2024-12-31) — Classesof Cash Receiptsfrom Operating Activities: 142376.00
CY5.AX balance_sheet (annual, 2024-12-31) — Common Stock: 92739029.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Common Stock: 92739029.00
CY5.AX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 71467357.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 71467357.00
CY5.AX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 13996000.00
CY5.AX cash_flow (annual, 2024-12-31) — Common Stock Payments: -673776.00
CY5.AX balance_sheet (annual, 2024-12-31) — Current Assets: 16125095.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Current Assets: 16125095.00
CY5.AX balance_sheet (annual, 2024-12-31) — Current Liabilities: 3599903.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 3599903.00
CY5.AX balance_sheet (annual, 2024-12-31) — Current Provisions: 141111.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Current Provisions: 141111.00
CY5.AX income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 42105.00
CY5.AX income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 42105.00
CY5.AX income_statement (annual, 2024-12-31) — Depreciation Income Statement: 42105.00
CY5.AX income_statement (annual, 2024-12-31) — Diluted Average Shares: 349580579.00
CY5.AX income_statement (annual, 2024-12-31) — Diluted EPS: -0.01
CY5.AX income_statement (annual, 2024-12-31) — EBIT: -2383299.00
CY5.AX income_statement (annual, 2024-12-31) — EBITDA: -2341194.00
CY5.AX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 28585.00
CY5.AX cash_flow (annual, 2024-12-31) — End Cash Position: 14869835.00
CY5.AX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 13322224.00
CY5.AX balance_sheet (annual, 2024-12-31) — Fixed Assets Revaluation Reserve: -376315.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Fixed Assets Revaluation Reserve: -376315.00
CY5.AX balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: 16828.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Foreign Currency Translation Adjustments: 16828.00
CY5.AX cash_flow (annual, 2024-12-31) — Free Cash Flow: -10301278.00
CY5.AX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 10435742.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 10435742.00
CY5.AX income_statement (annual, 2024-12-31) — General And Administrative Expense: 3245559.00
CY5.AX balance_sheet (annual, 2024-12-31) — Gross PPE: 62928719.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Gross PPE: 62928719.00
CY5.AX income_statement (annual, 2024-12-31) — Interest Expense: 40384.00
CY5.AX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 40384.00
CY5.AX income_statement (annual, 2024-12-31) — Interest Income: 227905.00
CY5.AX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 227905.00
CY5.AX cash_flow (annual, 2024-12-31) — Interest Paid Direct: -40384.00
CY5.AX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 40384.00
CY5.AX cash_flow (annual, 2024-12-31) — Interest Received Direct: 169700.00
CY5.AX balance_sheet (annual, 2024-12-31) — Invested Capital: 71467357.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Invested Capital: 71467357.00
CY5.AX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -5874660.00
CY5.AX balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 78515.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 78515.00
CY5.AX balance_sheet (annual, 2024-12-31) — Investments And Advances: 78515.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 78515.00
CY5.AX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 13996000.00
CY5.AX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1619454.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1619454.00
CY5.AX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 13322224.00
CY5.AX income_statement (annual, 2024-12-31) — Net Income: -3772569.00
CY5.AX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -3772569.00
CY5.AX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -3772569.00
CY5.AX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3772569.00
CY5.AX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3772569.00
CY5.AX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -3772569.00
CY5.AX income_statement (annual, 2024-12-31) — Net Interest Income: 187521.00
CY5.AX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 187521.00
CY5.AX cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 2503522.00
CY5.AX balance_sheet (annual, 2024-12-31) — Net PPE: 62671842.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Net PPE: 62671842.00
CY5.AX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -280291.00
CY5.AX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 71467357.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 71467357.00
CY5.AX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 3808192.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 3808192.00
CY5.AX balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 3808192.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 3808192.00
CY5.AX income_statement (annual, 2024-12-31) — Normalized EBITDA: -2341194.00
CY5.AX income_statement (annual, 2024-12-31) — Normalized Income: -3772569.00
CY5.AX income_statement (annual, 2024-12-31) — Operating Income: -5197321.00
CY5.AX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 848319650.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 848319650.00
CY5.AX cash_flow (annual, 2024-12-31) — Other Cash Paymentsfrom Operating Activities: -327583.00
CY5.AX cash_flow (annual, 2024-12-31) — Other Cash Receiptsfrom Operating Activities: 142376.00
CY5.AX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 10795229.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 10795229.00
CY5.AX income_statement (annual, 2024-12-31) — Other Gand A: 369154.00
CY5.AX income_statement (annual, 2024-12-31) — Other Income Expense: 2586117.00
CY5.AX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 2586117.00
CY5.AX income_statement (annual, 2024-12-31) — Other Operating Expenses: 1909657.00
CY5.AX balance_sheet (annual, 2024-12-31) — Other Payable: 1171289.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Other Payable: 1171289.00
CY5.AX balance_sheet (annual, 2024-12-31) — Other Properties: 61309265.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Other Properties: 61309265.00
CY5.AX balance_sheet (annual, 2024-12-31) — Other Receivables: 149433.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 149433.00
CY5.AX balance_sheet (annual, 2024-12-31) — Payables: 3458792.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Payables: 3458792.00
CY5.AX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 3458792.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 3458792.00
CY5.AX cash_flow (annual, 2024-12-31) — Paymentsto Suppliersfor Goodsand Services: -1867205.00
CY5.AX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 202314.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 202314.00
CY5.AX income_statement (annual, 2024-12-31) — Pretax Income: -2423683.00
CY5.AX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -280291.00
CY5.AX balance_sheet (annual, 2024-12-31) — Receivables: 1052946.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Receivables: 1052946.00
CY5.AX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 42105.00
CY5.AX income_statement (annual, 2024-12-31) — Rent And Landing Fees: 136183.00
CY5.AX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -673776.00
CY5.AX balance_sheet (annual, 2024-12-31) — Retained Earnings: -31707414.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -31707414.00
CY5.AX income_statement (annual, 2024-12-31) — Salaries And Wages: 2740222.00
CY5.AX income_statement (annual, 2024-12-31) — Selling General And Administration: 3245559.00
CY5.AX balance_sheet (annual, 2024-12-31) — Share Issued: 848319650.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Share Issued: 848319650.00
CY5.AX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 71467357.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 71467357.00
CY5.AX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 71467357.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 71467357.00
CY5.AX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CY5.AX income_statement (annual, 2024-12-31) — Tax Provision: 1348886.00
CY5.AX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.30
CY5.AX balance_sheet (annual, 2024-12-31) — Total Assets: 78875452.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Total Assets: 78875452.00
CY5.AX balance_sheet (annual, 2024-12-31) — Total Capitalization: 71467357.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 71467357.00
CY5.AX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 71467357.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 71467357.00
CY5.AX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 7408095.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 7408095.00
CY5.AX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 62750357.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 62750357.00
CY5.AX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3808192.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3808192.00
CY5.AX balance_sheet (annual, 2024-12-31) — Trading Securities: 78515.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Trading Securities: 78515.00
CY5.AX balance_sheet (annual, 2024-12-31) — Working Capital: 12525192.00
CY5.AX balance_sheet (quarterly, 2024-12-31) — Working Capital: 12525192.00
CY5.AX income_statement (annual, 2025-12-31) — +Operating Expense: 8550470.00
CY5.AX income_statement (annual, 2025-12-31) — +Total Revenue: 69224.38
CY5.AX balance_sheet (annual, 2025-12-31) — Accounts Payable: 2435016.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2435016.00
CY5.AX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -420912.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -420912.00
CY5.AX income_statement (annual, 2025-12-31) — Basic Average Shares: 959737128.00
CY5.AX income_statement (annual, 2025-12-31) — Basic EPS: -0.01
CY5.AX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 14869835.00
CY5.AX cash_flow (annual, 2025-12-31) — Capital Expenditure: -13003833.00
CY5.AX cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -12812424.00
CY5.AX balance_sheet (annual, 2025-12-31) — Capital Stock: 110301681.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 110301681.00
CY5.AX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 13351264.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 13351264.00
CY5.AX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13351264.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13351264.00
CY5.AX balance_sheet (annual, 2025-12-31) — Cash Financial: 13351264.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 13351264.00
CY5.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 17188788.00
CY5.AX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -13010891.00
CY5.AX cash_flow (annual, 2025-12-31) — Cash Flowsfromusedin Operating Activities Direct: -5680745.00
CY5.AX cash_flow (annual, 2025-12-31) — Changes In Cash: -1502848.00
CY5.AX cash_flow (annual, 2025-12-31) — Classesof Cash Payments: -6146199.00
CY5.AX cash_flow (annual, 2025-12-31) — Classesof Cash Receiptsfrom Operating Activities: 15580.00
CY5.AX balance_sheet (annual, 2025-12-31) — Common Stock: 110301681.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Common Stock: 110301681.00
CY5.AX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 84035916.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 84035916.00
CY5.AX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 18300000.00
CY5.AX cash_flow (annual, 2025-12-31) — Common Stock Payments: -1111212.00
CY5.AX balance_sheet (annual, 2025-12-31) — Current Assets: 14942436.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Current Assets: 14942436.00
CY5.AX balance_sheet (annual, 2025-12-31) — Current Liabilities: 2958909.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2958909.00
CY5.AX balance_sheet (annual, 2025-12-31) — Current Provisions: 261996.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Current Provisions: 261996.00
CY5.AX income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 133067.00
CY5.AX income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 133067.00
CY5.AX income_statement (annual, 2025-12-31) — Depreciation Income Statement: 133067.00
CY5.AX income_statement (annual, 2025-12-31) — Diluted Average Shares: 959737128.00
CY5.AX income_statement (annual, 2025-12-31) — Diluted EPS: -0.01
CY5.AX income_statement (annual, 2025-12-31) — EBIT: -7515824.00
CY5.AX income_statement (annual, 2025-12-31) — EBITDA: -7382757.00
CY5.AX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -15723.00
CY5.AX cash_flow (annual, 2025-12-31) — End Cash Position: 13351264.00
CY5.AX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 17188788.00
CY5.AX balance_sheet (annual, 2025-12-31) — Fixed Assets Revaluation Reserve: 312224.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Fixed Assets Revaluation Reserve: 312224.00
CY5.AX balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -394890.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -394890.00
CY5.AX cash_flow (annual, 2025-12-31) — Free Cash Flow: -18684578.00
CY5.AX income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 500.00
CY5.AX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 12980531.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 12980531.00
CY5.AX income_statement (annual, 2025-12-31) — General And Administrative Expense: 5094605.00
CY5.AX balance_sheet (annual, 2025-12-31) — Gross PPE: 75514437.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 75514437.00
CY5.AX income_statement (annual, 2025-12-31) — Gross Profit: 69224.38
CY5.AX income_statement (annual, 2025-12-31) — Interest Expense: 23058.00
CY5.AX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 23058.00
CY5.AX income_statement (annual, 2025-12-31) — Interest Income: 449874.00
CY5.AX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 449874.00
CY5.AX cash_flow (annual, 2025-12-31) — Interest Received Direct: 449874.00
CY5.AX balance_sheet (annual, 2025-12-31) — Invested Capital: 84035916.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 84035916.00
CY5.AX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -13010891.00
CY5.AX balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 767054.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 767054.00
CY5.AX balance_sheet (annual, 2025-12-31) — Investments And Advances: 767054.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 767054.00
CY5.AX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 18300000.00
CY5.AX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1686168.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1686168.00
CY5.AX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 17188788.00
CY5.AX income_statement (annual, 2025-12-31) — Net Income: -7538882.00
CY5.AX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -7538882.00
CY5.AX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -7538882.00
CY5.AX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -7538882.00
CY5.AX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -7538882.00
CY5.AX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -7538882.00
CY5.AX income_statement (annual, 2025-12-31) — Net Interest Income: 426816.00
CY5.AX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -54135.00
CY5.AX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 426816.00
CY5.AX cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 46577.00
CY5.AX balance_sheet (annual, 2025-12-31) — Net PPE: 75093525.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Net PPE: 75093525.00
CY5.AX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -190909.00
CY5.AX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 84035916.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 84035916.00
CY5.AX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 3808192.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 3808192.00
CY5.AX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3808192.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3808192.00
CY5.AX income_statement (annual, 2025-12-31) — Normalized EBITDA: -7383257.00
CY5.AX income_statement (annual, 2025-12-31) — Normalized Income: -7539382.00
CY5.AX income_statement (annual, 2025-12-31) — Operating Income: -8481245.62
CY5.AX income_statement (annual, 2025-12-31) — Operating Revenue: 69224.38
CY5.AX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1064424968.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1064424968.00
CY5.AX cash_flow (annual, 2025-12-31) — Other Cash Paymentsfrom Operating Activities: -533107.00
CY5.AX cash_flow (annual, 2025-12-31) — Other Cash Receiptsfrom Operating Activities: 15580.00
CY5.AX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 13063197.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 13063197.00
CY5.AX income_statement (annual, 2025-12-31) — Other Gand A: 1267981.00
CY5.AX income_statement (annual, 2025-12-31) — Other Income Expense: -7129.00
CY5.AX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 2.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 2.00
CY5.AX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -7629.00
CY5.AX income_statement (annual, 2025-12-31) — Other Operating Expenses: 3322798.00
CY5.AX balance_sheet (annual, 2025-12-31) — Other Payable: 261897.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Other Payable: 261897.00
CY5.AX balance_sheet (annual, 2025-12-31) — Other Properties: 73828269.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Other Properties: 73828269.00
CY5.AX balance_sheet (annual, 2025-12-31) — Other Receivables: 1234318.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1234318.00
CY5.AX balance_sheet (annual, 2025-12-31) — Payables: 2696913.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Payables: 2696913.00
CY5.AX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2696913.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2696913.00
CY5.AX cash_flow (annual, 2025-12-31) — Paymentsto Suppliersfor Goodsand Services: -5613092.00
CY5.AX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 356854.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 356854.00
CY5.AX income_statement (annual, 2025-12-31) — Pretax Income: -7538882.00
CY5.AX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -54135.00
CY5.AX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -191409.00
CY5.AX balance_sheet (annual, 2025-12-31) — Receivables: 1234318.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Receivables: 1234318.00
CY5.AX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 133067.00
CY5.AX income_statement (annual, 2025-12-31) — Rent And Landing Fees: 93029.00
CY5.AX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -1111212.00
CY5.AX balance_sheet (annual, 2025-12-31) — Retained Earnings: -39246296.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -39246296.00
CY5.AX income_statement (annual, 2025-12-31) — Salaries And Wages: 3733595.00
CY5.AX cash_flow (annual, 2025-12-31) — Sale Of PPE: 500.00
CY5.AX income_statement (annual, 2025-12-31) — Selling General And Administration: 5094605.00
CY5.AX balance_sheet (annual, 2025-12-31) — Share Issued: 1064424968.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Share Issued: 1064424968.00
CY5.AX income_statement (annual, 2025-12-31) — Special Income Charges: 500.00
CY5.AX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 84035916.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 84035916.00
CY5.AX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 84035916.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 84035916.00
CY5.AX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CY5.AX income_statement (annual, 2025-12-31) — Tax Provision: 0.00
CY5.AX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CY5.AX balance_sheet (annual, 2025-12-31) — Total Assets: 90803017.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Total Assets: 90803017.00
CY5.AX balance_sheet (annual, 2025-12-31) — Total Capitalization: 84035916.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 84035916.00
CY5.AX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 84035916.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 84035916.00
CY5.AX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 6767101.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6767101.00
CY5.AX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 75860581.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 75860581.00
CY5.AX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3808192.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3808192.00
CY5.AX income_statement (annual, 2025-12-31) — Total Unusual Items: 500.00
CY5.AX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 500.00
CY5.AX balance_sheet (annual, 2025-12-31) — Trading Securities: 767054.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Trading Securities: 767054.00
CY5.AX balance_sheet (annual, 2025-12-31) — Working Capital: 11983527.00
CY5.AX balance_sheet (quarterly, 2025-12-31) — Working Capital: 11983527.00
CYAB income_statement (annual, 2022-12-31) — +Operating Expense: 6205000.00
CYAB income_statement (annual, 2022-12-31) — +Total Revenue: 798000.00
CYAB balance_sheet (annual, 2022-12-31) — Accounts Payable: 160000.00
CYAB balance_sheet (annual, 2022-12-31) — Accounts Receivable: 86000.00
CYAB balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -34000.00
CYAB balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2078000.00
CYAB income_statement (annual, 2022-12-31) — Basic Average Shares: 13814167.00
CYAB income_statement (annual, 2022-12-31) — Basic EPS: -0.44
CYAB cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1244000.00
CYAB cash_flow (annual, 2022-12-31) — Capital Expenditure: -125000.00
CYAB balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 157000.00
CYAB balance_sheet (annual, 2022-12-31) — Capital Stock: 5504000.00
CYAB balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1758000.00
CYAB balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1758000.00
CYAB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 5213000.00
CYAB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -125000.00
CYAB cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -4468000.00
CYAB cash_flow (annual, 2022-12-31) — Change In Account Payable: 24000.00
CYAB cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -95000.00
CYAB cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 4000.00
CYAB cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 1020000.00
CYAB cash_flow (annual, 2022-12-31) — Change In Payable: 24000.00
CYAB cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 24000.00
CYAB cash_flow (annual, 2022-12-31) — Change In Receivables: -25000.00
CYAB cash_flow (annual, 2022-12-31) — Change In Working Capital: 928000.00
CYAB cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -25000.00
CYAB cash_flow (annual, 2022-12-31) — Changes In Cash: 620000.00
CYAB balance_sheet (annual, 2022-12-31) — Common Stock: 2000.00
CYAB balance_sheet (annual, 2022-12-31) — Common Stock Equity: -10314000.00
CYAB cash_flow (annual, 2022-12-31) — Common Stock Issuance: 150000.00
CYAB income_statement (annual, 2022-12-31) — Cost Of Revenue: 274000.00
CYAB balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 65000.00
CYAB balance_sheet (annual, 2022-12-31) — Current Assets: 1971000.00
CYAB balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 116000.00
CYAB balance_sheet (annual, 2022-12-31) — Current Debt: 301000.00
CYAB balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 417000.00
CYAB balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 771000.00
CYAB balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 771000.00
CYAB balance_sheet (annual, 2022-12-31) — Current Liabilities: 1970000.00
CYAB cash_flow (annual, 2022-12-31) — Depreciation: 28000.00
CYAB cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 28000.00
CYAB cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 28000.00
CYAB balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 2436000.00
CYAB income_statement (annual, 2022-12-31) — Diluted Average Shares: 13814167.00
CYAB income_statement (annual, 2022-12-31) — Diluted EPS: -0.44
CYAB income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -6061000.00
CYAB income_statement (annual, 2022-12-31) — EBIT: -5925000.00
CYAB income_statement (annual, 2022-12-31) — EBITDA: -5897000.00
CYAB cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -100000.00
CYAB cash_flow (annual, 2022-12-31) — End Cash Position: 1764000.00